Parliament insists EMA sorts out conflicts policies by June to resolve budget hold-up
This article was originally published in Scrip
Executive Summary
The European Parliament on 10 May postponed signing off the European Medicines Agency's accounts for the financial year 2009 in light of, among other things, concerns that there is no proper guarantee of the independence of experts hired to carry out scientific evaluations of human medicines at the agency.
You may also be interested in...
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Regulators Explain How To Ensure Transitioned Trials Align With CTR
Members of the EU’s Clinical Trials Coordination Group have developed harmonized requirements for updating trials that are transitioned to the Clinical Trials Information System based on a minimum set of documents.
Global Medtech Guidance Tracker: March 2024
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Fifty-nine documents have been posted on the tracker since its last update.